ÅǸ޴º
¹øÈ£ | ±¸ºÐ | Á¦¸ñ |
---|---|---|
233 | (±¹¿Ü)SCIE | Association study of miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms with venous thromboembolism in a Korean population |
232 | (±¹¿Ü)SCIE | A novel PI3K/mTOR dual inhibitor, CMG002, overcomes the chemoresistance in ovarian cancer |
231 | (±¹¿Ü)SCI | Robotic transduodenal ampullectomy: A novel minimallyinvasive approach for ampullary neoplasms |
230 | (±¹¿Ü)SCI | Randomized phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer |
229 | (±¹³»)KCI | Eculizumab Ä¡·á·Î È£ÀüµÈ ºñÁ¤Çü ¿ëÇ÷¿äµ¶ÁõÈıº 1¿¹ |
228 | (±¹¿Ü)SCI | Tumor microenvironment remodeling by intratumoral oncolytic vaccinia virus enhances the efficacy of immune checkpoint blockade |
227 | (±¹³»)SCOPUS | Prevalence and Risk Factor of Venous Thromboembolism in Korean Patients with Congestive Heart Failure |
226 | (±¹¿Ü)±âŸ | Predictive factors for treatment response using dual-energy computed tomography in patients with advanced lung adenocarcinoma |
225 | (±¹³»)SCIE | Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns, and Outcomes in Very Elderly Patients with Diffuse Large B-Cell Lymphoma: The Korean Cancer Study Group LY16-01 |
224 | (±¹¿Ü)SCI | The Clinical Implications of FDG-PET/CT Differ According to Histology in Advanced Gastric Cancer |
Copyright ¨Ï chamc, All rights reserved.